Penumbra (PEN) Net Income (QoQ) (2014 - 2026)
Penumbra (PEN) Net Income (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn |
| 10 | Penumbra | 12.56 Bn | 11.95 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31.17% |
| Dec 31, 2025 | 3.25% |
| Sep 30, 2025 | 1.19% |
| Jun 30, 2025 | 15.52% |
| Mar 31, 2025 | 16.45% |
| Dec 31, 2024 | 14.26% |
| Sep 30, 2024 | 148.97% |
| Jun 30, 2024 | -647.17% |
| Mar 31, 2024 | -79.71% |
| Dec 31, 2023 | 488.43% |
| Sep 30, 2023 | -51.34% |
| Jun 30, 2023 | 121.16% |
| Mar 31, 2023 | 120.84% |
| Dec 31, 2022 | 270.72% |
| Sep 30, 2022 | 38.41% |
| Jun 30, 2022 | -4,767.09% |
| Mar 31, 2022 | 100.32% |
| Dec 31, 2021 | -406.72% |
| Sep 30, 2021 | -3.23% |
| Jun 30, 2021 | -24.04% |